India-founded sleeptech startup DUSQ has become the fastest Indian startup to surpass USD 1 million in revenue on Kickstarter, achieving the milestone within just days of launching its US crowdfunding campaign on June 9, 2026. The achievement marks a significant milestone for India’s consumer hardware ecosystem and highlights the growing global demand for innovative, India-built healthcare technology.
Unlike traditional wearable brands such as Oura, Whoop, and Garmin, DUSQ chose a different path by developing what it describes as the world’s first closed-loop sleep regulation system. Instead of merely tracking sleep patterns, the company’s wearable device actively improves sleep quality through real-time physiological monitoring and adaptive nerve stimulation.
Moreover, DUSQ designed, engineered, tested, and clinically validated the lightweight behind-the-ear device entirely in India through its in-house sleep laboratory. Following its successful Kickstarter debut, the company has started shipping the device to US backers ahead of its planned nationwide retail launch in September 2026.
The record-breaking campaign also positions DUSQ among a select group of Indian consumer hardware startups that have gained meaningful traction in the highly competitive US market. Additionally, the company surpassed every previous Indian healthtech campaign on Kickstarter, including Ultrahuman’s Ring campaign, which raised nearly USD 500,000.
Since securing a three-Shark deal on Shark Tank India less than two years ago, DUSQ has rapidly expanded its presence. Furthermore, the company has already served more than 2,000 first-generation commercial users in India while building a Kickstarter waitlist exceeding 10,000 prospective customers.
DUSQ’s flagship sleep regulation system weighs only 12 grams and measures 7.2 millimetres, enabling users to wear it comfortably behind the ear throughout the night. The device continuously monitors the autonomic nervous system and immediately responds whenever sleep disruptions occur. Consequently, it delivers adaptive vagus and vestibular nerve stimulation to help users return to deeper sleep before they even notice the interruption.
Unlike conventional sleep trackers that provide post-sleep analytics, DUSQ focuses on improving sleep while it happens. The company developed this technology entirely through its proprietary research infrastructure.
To support its innovation, DUSQ’s in-house sleep laboratory has collected more than 50 million physiological data points. Additionally, the company has completed one clinical trial while conducting another ongoing study. It also holds CDSCO certification in India and utilizes an FDA-cleared stimulation modality for insomnia treatment.
According to the company, its double-blind controlled clinical trials demonstrated impressive outcomes, including 31% more deep sleep, 38% improvement in heart rate variability, and 22% fewer nighttime awakenings.
Furthermore, DUSQ introduced Sleep Quotient (SQ), its proprietary metric that measures the body’s ability to generate restorative sleep rather than simply evaluating sleep quality after the fact. Developing SQ required expertise across hardware engineering, signal processing, biostatistics, and real-time artificial intelligence algorithms, making it one of the company’s key technological differentiators.
Commenting on the milestone, Dr. Siddhant Bhargava, Co-founder and CEO of DUSQ, said, “We did not enter a category. We built one. From India. That is what these million dollars represent, not a product win or a category win.”
Meanwhile, Gursakhi Lugani, Chief Taste Officer at DUSQ, said, “Sleep is too personal to be sold through hype. Most brands borrow desire from culture; we had to build our own. A million-dollar opening tells us people were willing to believe in a future of sleep they hadn’t experienced yet.”
The company’s growth has also attracted strong investor backing. DUSQ previously secured approximately USD 3 million in seed funding through a round led by Fireside Ventures, with participation from Antler India and Climber Capital.
As it prepares for its broader US retail expansion, DUSQ is significantly strengthening its India-based workforce. The company currently has more than 50 open positions across hardware engineering, embedded systems, biotechnology, signal processing, product design, growth, customer success, sleep coaching, operations, and content.
Highlighting the company’s engineering vision, Mitansh Khurana, who leads technology at DUSQ, said, “The problems we are solving here do not exist as job descriptions anywhere else. We are building the sensing, stimulation, and intelligence layers simultaneously on real human physiology in real time. If that sounds hard, it is. That is exactly the point.”
Similarly, Shalmali Kadu, who leads product at DUSQ, emphasized the company’s interdisciplinary approach, stating that solving complex healthcare challenges requires combining engineering, science, empathy, and curiosity.
Additionally, Ronak Shah, Growth Advisor at DUSQ, said, “I have helped scale consumer brands to nine figures in revenue, and I have never seen a product where the technology this early actually matches the ambition of the pitch. If you want to build something that has to work, not just look good in a deck, this is the place to do it.”
DUSQ’s rapid success on Kickstarter demonstrates the growing global recognition of India’s innovation in consumer health technology. By combining AI-driven sleep science, clinical validation, and proprietary hardware, the company has established itself as a strong contender in the global sleeptech market. As DUSQ accelerates its US expansion and strengthens its India-based operations, it is well-positioned to redefine the future of sleep technology while elevating India’s presence in the global medtech and wearable technology industry.
